EMEA-001200-PIP01-11

Key facts

Active substance	Proteinase, metallo- (synthetic nociceptin receptor-binding) 1290102-81-6 (AGN214868)
Therapeutic area	Pain
Decision number	P/0030/2013
PIP number	EMEA-001200-PIP01-11
Pharmaceutical form(s)	Powder for solution for injection
Condition(s) / indication(s)	Treatment of overactive bladder Treatment of postherpetic neuralgia
Route(s) of administration	Intradermal use Intramuscular use
Contact for public enquiries	Allergan Pharmaceuticals Ireland Ireland Tel. +44 (0)1628 494026 Fax +44 (0)1628 494058 E-mail: uk_medinfo@allergan.com
Decision type	P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

List item

P/0030/2013: EMA decision of 26 February 2013 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for proteinase, metallo- (synthetic nociceptin receptor-... (PDF/89.78 KB)

Adopted

First published: 23/04/2013
Last updated: 23/04/2013
EMA/24831/2013

Related documents

List item

Proteinase, metallo- (synthetic nociceptin receptor-binding) 1290102-81-6 (also referred to as AGN-214868 or senrebotase) - Notification of discontinuation of a paediatric development which is covered by an agreed paedia... (PDF/20.1 KB)

First published: 13/04/2016
Last updated: 13/04/2016
EMEA-001200-PIP01-11

How useful was this page?

Add your rating

★ ★ ★ ★ ★